Bio-Gate AG
Important Dates
Bio-Gate AG's next confirmed earnings release is scheduled for March 3, 2027.
| Earnings Date | 3/3/2027 |
Share Statistics
As of December 31, 2025, Bio-Gate AG has 2.04M shares outstanding.
| Shares Outstanding | 2.04M |
Financial Position
As of December 31, 2025, Bio-Gate AG maintains a current ratio of 2.46, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.46 |
| Quick Ratio | 0.62 |
| Debt / Equity | 3.29 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 23.00 |
Stock Price Statistics
EURAs of the close on October 22, 2026, Bio-Gate AG's stock has declined approximately 61.33% over the past 52 weeks. The 50-day moving average sits at 2.71, while the 200-day moving average is 9.74.
| 52-Week Price Change | -61.33% |
| 50-Day Moving Average | 2.71 |
| 200-Day Moving Average | 9.74 |
Balance Sheet
EURAs of December 31, 2025, Bio-Gate AG holds 704,933.50 in cash and equivalents against 52,535.98 in total debt, resulting in a net debt position of -652,397.52. Total book value stands at 1.53M, with working capital of 1.66M providing operational flexibility.
| Cash & Cash Equivalents | 704,933.50 |
| Total Debt | 52,535.98 |
| Net Debt | -652,397.52 |
| Equity (Book Value) | 1.53M |
| Book Value Per Share | 0.75 |
| Working Capital | 1.66M |
Stock Splits
Bio-Gate AG's most recent stock split took place on July 28, 2026 with a 5:1 split ratio.
| Last Split Date | 7/28/2026 |
| Split Ratio | 5:1 |